Hydreight reported record Topline(1) Revenue of $10.46M in the first 6 months of 2024. Q2, 2024 GAAP revenue was $4.10 million an increase of 52% compared to Q2, 2023. Q2, 2024 Adjusted EBITDA(1) was $218K compared to ($456K) in the comparative quarter. In partnership with two other companies, Hydreight launched Telemedicine and e-Commerce Solution that […]
Scilex Holding Company seeks to maximize the value of its stockholders, including by way of conducting a spinoff or public listing of securities of Scilex Pharmaceuticals (“Scilex Pharma”) in markets and on securities exchanges in or outside of the U.S., including Hong Kong. Scilex Holding Company management believes the potential value of Scilex Pharma may
SEATTLE, Oct. 16, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today is celebrating the first shipment and patient dosing from its second manufacturing facility for the production of its 203Pb- and 212Pb-labeled radiopharmaceuticals. Located
Megan Baldwin, PhD, MAICD, to retire from the Board and has chosen not to stand for re-election As Founder and Chief Innovation Officer, Dr. Baldwin will continue focusing on advancing Opthea’s innovation agenda MELBOURNE, Australia and PRINCETON, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) — Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company
All amounts expressed in US dollars TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) (“Barrick” or the “Company”) today reported preliminary Q3 production of 943 thousand ounces of gold and 48 thousand tonnes of copper, as well as preliminary Q3 sales of 967 thousand ounces of gold and 42 thousand tonnes of
Schaumburg, IL, Oct. 16, 2024 (GLOBE NEWSWIRE) — The American Society for Dermatologic Surgery Association (ASDSA) is pleased to announce the recipients of its annual Patient Safety Hero Award awarded at the ASDS / ASDSA Annual Meeting. This year’s award is being presented to members who have taken an active role in promoting and protecting
Schaumburg, IL, Oct. 16, 2024 (GLOBE NEWSWIRE) — The American Society for Dermatologic Surgery Association (ASDSA) is pleased to announce the 2024 Top Advocates during the ASDS / ASDSA Annual Meeting. Advocates are chosen based on their superior contributions to ASDSA’s advocacy efforts throughout the year and demonstrated commitment to patient safety in the field
Company to host a webinar on the detailed VALIANT results at 12:30 p.m. PT on Saturday, October 26 WALTHAM, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the abstract of the Phase 3 VALIANT study of pegcetacoplan in C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN)
ST. JAMES, N.Y., Oct. 16, 2024 (GLOBE NEWSWIRE) — Gyrodyne, LLC (NASDAQ: GYRO) (“Gyrodyne”) today announced that the Supreme Court of the State of New York issued a decisive ruling in favor of Gyrodyne, dismissing a petition brought by the St. James – Head of the Harbor Neighborhood Preservation Coalition, Inc. and several individuals seeking
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) — Nobel Resources Corp. (TSX-V: NBLC; OTCQB: NBTRF) (the “Company” or “Nobel”) announces that it has extended the closing of its